Late-breaking new independent validation study of 1,674 patients demonstrates castle biosciences' i31-gep artificial intelligence algorithm improves precision of sentinel lymph node positivity prediction in cutaneous melanoma

Friendswood, texas--(business wire)---- $cstl #castlebiosciences--castle presented new data on the integration of the decisiondx®-melanoma test with clinicopathologic features (i31-gep).
CSTL Ratings Summary
CSTL Quant Ranking